PCM
RCKT icon

Penserra Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Penserra Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,455
Closed -$43K – 1513
2021
Q3 		$43K Buy
1,455
+10
+0.7% +$364 ﹤0.01% 1091
2021
Q2 		$63K Buy
1,445
+75
+5% +$3.26K ﹤0.01% 937
2021
Q1 		$60K Buy
1,370
+95
+7% +$5.22K ﹤0.01% 789
2020
Q4 		$69K Buy
1,275
+803
+170% +$29.3K ﹤0.01% 648
2020
Q3 		$10K Buy
+472
New +$11.6K ﹤0.01% 814

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return